Atilla Aynur, Çelik Merve, Çolak Özkul Yılmaz, Kuruoğlu Tuba, Temoçin Fatih, Kelkitli Engin, Birinci Asuman
Ondokuz Mayıs University Faculty of Medicine, Department of Infectious Disease and Clinical Microbiology, Samsun, Turkey.
Ondokuz Mayıs University Faculty of Medicine, Division of Hematology, Samsun, Turkey.
Mikrobiyol Bul. 2022 Apr;56(2):315-325. doi: 10.5578/mb.20229810.
Invasive fungal infections (IFI) continue to be an important cause of morbidity and mortality in patients with hematological malignancies. Candida and Aspergillus species constitute most of the IFI in these patients.. It has been reported that most of the invasive aspergillosis epidemics are related to the construction works in the hospital. In this study, we aimed to investigate the frequency of IFI in the old and the new hospital building after relocation in patients with hematological malignancies. Of 8042 patients who were hospitalized in the Department of Hematology, Ondokuz Mayıs University Faculty of Medicine between January 2015 and September 2019, 412 patients who were initiated antifungal therapy were included in the study. The patients in the hematology clinic, which were moved to the new oncology hospital building in January 2018, were grouped as prior and after relocation, and their demographical data, hematological diagnosis, chemotherapy regimens, mortality, IFI, focus of infection, presence of central venous catheter, antifungal prophylaxis and treatment, galactomannan level, fungal culture and computed tomography (CT) findings were evaluated retrospectively. It was determined that 55% of the patients were male and the median age was 58 (range:18-93). The rate of IFI development was 5.12% (n= 412) and the rate of invasive mold infection was 1.2% (n= 145). The most common hematological disease for which antifungal treatment initiated was acute myeloid leukemia (AML) with a rate of 50% (n= 206/412). Of patients, 73% received induction chemotherapy (42%, first induction, 31% reinduction), 13.4% received consolidation therapy. Invasive mold infection was diagnosed as 40% possible, 59% probable, 1% proven. While patients had similar characteristics such as age, gender, hematological disease, chemotherapy regimens and antifungal prophylaxis prior and after transportation, the rate of development of invasive mold infection was 2.1%, 2.06 / 1000 patient days, before transportation, 1.37% (p= 0.009), 1.15/1000 patient days (p<0.001) after transportation, and it was statistically significantly lower after transportation. The median value of galactomannan antigen was detected as 0.17 (0.02-5.9). Blood cultures revealed 10.3% fungal growth and the most common growth was Candida albicans with 54.8% and Mucor spp. as mold with 3.2%. Large-scale construction works such as renovation, extension and demolition works in old hospital buildings are a permanent condition in different units. Clinicians should be aware of that infections due to opportunistic fungi can be seen in immunosuppressive patients close to such construction sites, and even cause epidemics. It should be kept in mind that these infections, which can progress with serious morbidity and mortality are difficult to treat but can be prevented by infection control measures.
侵袭性真菌感染(IFI)仍然是血液系统恶性肿瘤患者发病和死亡的重要原因。念珠菌和曲霉菌是这些患者中大多数IFI的病原体。据报道,大多数侵袭性曲霉病的流行与医院的建筑工程有关。在本研究中,我们旨在调查血液系统恶性肿瘤患者搬迁至新老医院大楼后IFI的发生频率。2015年1月至2019年9月期间,在翁多库兹迈伊斯大学医学院血液科住院的8042例患者中,412例开始抗真菌治疗的患者被纳入研究。2018年1月迁至新建肿瘤医院大楼的血液科门诊患者,按搬迁前后分组,回顾性评估其人口统计学数据、血液学诊断、化疗方案、死亡率、IFI、感染部位、中心静脉导管的存在、抗真菌预防和治疗、半乳甘露聚糖水平、真菌培养和计算机断层扫描(CT)结果。确定55%的患者为男性,中位年龄为58岁(范围:18 - 93岁)。IFI的发生率为5.12%(n = 412),侵袭性霉菌感染率为1.2%(n = 145)。启动抗真菌治疗最常见的血液系统疾病是急性髓系白血病(AML),发生率为50%(n = 206/412)。患者中,73%接受诱导化疗(42%为首次诱导,31%为再次诱导),13.4%接受巩固治疗。侵袭性霉菌感染确诊为可能40%、很可能59%、确诊1%。虽然患者在转运前后年龄、性别、血液系统疾病、化疗方案和抗真菌预防等特征相似,但侵袭性霉菌感染的发生率在转运前为2.1%,2.06/1000患者日,转运后为1.37%(p = 0.009),1.15/1000患者日(p < 0.001),转运后在统计学上显著降低。半乳甘露聚糖抗原的中位值检测为0.17(0.02 - 5.9)。血培养显示10.3%的真菌生长,最常见的生长菌是白色念珠菌,占54.8%,毛霉属霉菌占3.2%。旧医院大楼的翻新、扩建和拆除等大规模建筑工程在不同科室是常态。临床医生应意识到,在靠近此类建筑工地的免疫抑制患者中可能会出现机会性真菌感染,甚至引发疫情。应牢记这些感染可能进展为严重的发病和死亡,难以治疗,但可通过感染控制措施预防。